| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $128,708 | 6 | 100 |
Sells | $0 | 0 | 0 |
| Silverman Joshua | CEO and President | 3 | $80,476 | 0 | $0 | $80,476 |
| SCHECHTER JONATHAN | director | 3 | $48,232 | 0 | $0 | $48,232 |
PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites. Central to their efforts is Cell-in-a-Box, their proprietary encapsulation technology which utilizes cellulose to enclose live cells. This innovative platform serves as the foundation for treatments aimed at diverse cancers, such as advanced and inoperable pancreatic cancer, as well as …
Over the last 12 months, insiders at PharmaCyte Biotech, Inc. have bought $128,708 and sold $0 worth of PharmaCyte Biotech, Inc. stock.
On average, over the past 5 years, insiders at PharmaCyte Biotech, Inc. have bought $128,708 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Silverman Joshua (CEO and President) — $80,476. SCHECHTER JONATHAN (director) — $48,232.
The last purchase of 40,000 shares for transaction amount of $33,316 was made by Silverman Joshua (CEO and President) on 2026‑01‑07.
| 2026-01-07 | Silverman Joshua | CEO and President | 40,000 0.5712% | $0.83 | $33,316 | -16.28% | ||
| 2026-01-07 | SCHECHTER JONATHAN | director | 20,000 0.2893% | $0.84 | $16,872 | -16.28% | ||
| 2026-01-06 | Silverman Joshua | CEO and President | 30,000 0.4058% | $0.79 | $23,667 | -9.98% | ||
| 2026-01-06 | SCHECHTER JONATHAN | director | 20,000 0.271% | $0.79 | $15,808 | -9.98% | ||
| 2026-01-05 | Silverman Joshua | CEO and President | 30,000 0.4028% | $0.78 | $23,493 | -8.79% | ||
| 2026-01-05 | SCHECHTER JONATHAN | director | 20,000 0.2666% | $0.78 | $15,552 | -8.79% |
| Increased Positions | 13 | +48.15% | 615,027 | +141.93% |
| Decreased Positions | 8 | -29.63% | 64,167 | -14.81% |
| New Positions | 8 | New | 343,250 | New |
| Sold Out Positions | <1 | Sold Out | <1 | Sold Out |
| Total Postitions | 32 | +18.52% | 984,178 | +127.13% |